Analgesics in Slovakia

October 2023 | 24 pages | ID: ADDCA9E20A2EN
Euromonitor International Ltd

Abstracts

Diclofenac and naproxen are non-steroidal anti-inflammatory analgesics used to relieve mild pain. Both categories saw retail current value sales surge in 2022. Retail current value sales are set to continue to grow over 2023 in both categories, albeit at a slower rate. In retail volume terms, diclofenac witnessed a spike in 2022, with slower growth anticipated over 2023. Meanwhile, naproxen followed fast retail volume growth in 2021 with a moderate increase in 2022. Demand is set to drop in 2023...

Euromonitor International's Analgesics in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

ANALGESICS IN SLOVAKIA
KEY DATA FINDINGS
2023 DEVELOPMENTS
Diclofenac and naproxen gain traction as alternatives to best sellers
Supply issues among analgesics trigger demand and stockpiling
Ageing and active population trends drive topical analgesics/anaesthetic
PROSPECTS AND OPPORTUNITIES
Positive outlook for analgesics in Slovakia over the forecast period
Ongoing discussion over deregulation of analgesics distribution
Private label is set to increase penetration of analgesics, but most consumers are expected to remain brand loyal
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2018-2023
Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN SLOVAKIA
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Distribution of Consumer Health by Format: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format and Category: % Value 2023
Table 15 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2022-2023
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources